Looser Restrictions on HRAs on the Horizon
Four things you need to know about the Trump Administration’s proposed regs.
Nine Ways to Deal with Escalating Drug Costs
As drug costs continue to increase at an unsustainable rate, some hospitals are finding new solutions.
Time to Address ‘Financial Toxicity’ of Cancer Treatment
More affordable, more collaborative, and more personalized care is our cancer care challenge. Here’s how we get there.
CAR T-cell Therapy: How Payers are Responding to Huge Price Tags
This revolutionary therapy raises serious financial questions. Here’s how much it costs, and how payers are responding.
Medical Foods Strive for Insurance Coverage
These products aid in treating several conditions, but are insurers paying for them? Find out.
New Chiefs at MCOs: 4 Positions You May Want to Add
A chief executive officer must have a more diverse team to address the rising complexity and velocity of healthcare. Here are four positions that managed care organizations may want to seriously consider.
Eight Predictions for Cancer Care in 10 Years
Experts predict what oncology care will look like a decade from now.
Eight Top Oncology Drug Approvals
New cancer drugs continue to offer patients hope. Here are eight of them.
Is Precision Medicine Worth the Hype? Oncologists Weigh In
New Cardinal Health Specialty Solutions research shares inside information about oncologists’ views about targeted therapies.
